Isolation and characterization of Escherichia coli sequence type 131 and other antimicrobial-resistant Gram-negative bacilli from clinical stool samples from veterans

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 8, 2016, Pages 4638-4645

  Mohamed, Muhanad ^a   Clabots, Connie ^b   Porter, Stephen B ^b   Thuras, Paul ^b   Johnson, James R ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; LEVOFLOXACIN; NALIDIXIC ACID; NITROFURANTOIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; ANTIINFECTIVE AGENT; BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; QUINOLONE DERIVATIVE;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CITROBACTER FREUNDII; CITROBACTER KOSERI; CLONAL VARIATION; CROSS-SECTIONAL STUDY; DIARRHEA; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FECES ANALYSIS; FLAVIMONAS ORYZIHABITANS; GENOTYPE; GRAM NEGATIVE BACTERIUM; HAFNIA ALVEI; HUMAN; KLEBSIELLA PNEUMONIAE; MOLECULAR PHYLOGENY; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS FLUORESCENS; PULSED FIELD GEL ELECTROPHORESIS; VETERAN; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PHYLOGENY; PROCEDURES;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; GENOTYPE; GRAM-NEGATIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; VETERANS;

EID: 84979545279     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00383-16     Document Type: Article

References (32)

1. Russo TA, Johnson JR. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: an overlooked epidemic. Microbes Infect 5:449-456. http://dx.doi.org/10.1016/S1286-4579(03)00049-2.
2. Gupta K, Scholes D, Stamm WE. 1999. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 281:736-738. http://dx.doi.org/10.1001/jama.281.8.736.
3. Gupta K, Hooton TM, Stamm WE. 2001. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 135:41-50. http://dx.doi.org/10.7326/0003-4819-135-1-200107030-00012.
4. Madeiros AA. 1993. Nosocomial outbreaks of multiresistant bacteria: extended-spectrum beta-lactamases have arrived in North America. Ann Intern Med 119:428-430. http://dx.doi.org/10.7326/0003-4819-119-5-199309010-00015.
5. Colpan AJB, Porter S, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR, VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) investigators. 2013. Escherichia coli sequence type 131 (ST131) as an emergent multidrug-resistant pathogen among U.S. veterans. Clin Infect Dis 57:1256-1265. http://dx.doi.org/10.1093/cid/cit503.
6. Ender PT, Gajanana D, Johnston B, Clabots C, Tamarkin FJ, Johnson JR. 2009. Transmission of an extended-spectrum-beta-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and emphysematous pyelonephritis. J Clin Microbiol 47:3780-3782. http://dx.doi.org/10.1128/JCM.01361-09.
7. Nicolas-Chanoine MH, Bertrand X, Madec JY. 2014. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 27:543-574. http://dx.doi.org/10.1128/CMR.00125-13.
8. Lopez-Cerero L, Navarro MD, Bellido M, Martin-Pena A, Vinas L, Cisneros JM, Gomez-Langley SL, Sanchez-Monteseirin H, Morales I, Pascual A, Rodriguez-Bano J. 2014. Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications. J Antimicrob Chemother 69:809-814. http://dx.doi.org/10.1093/jac/dkt405.
9. Denisuik AJ, Lagace-Wiens PR, Pitout JD, Mulvey MR, Simner PJ, Tailor F, Karlowsky JA, Hoban DJ, Adam HJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance. 2013. Molecular epidemiology of extended-spectrum beta-lactamase-, AmpC beta-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11. J Antimicrob Chemother 68(Suppl 1):i57-i65. http://dx.doi.org/10.1093/jac/dkt027.
10. Johnson JR, Stell AL. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 181:261-272. http://dx.doi.org/10.1086/315217.
11. Johnson JR, Kuskowski MA, Owens K, Soto S, Horcajada JP, Jimenez de Anta MT, Vila J. 2005. Extended virulence genotypes of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J Infect Dis 191:46-50. http://dx.doi.org/10.1086/426450.
12. Clermont O, Christenson JK, Denamur E, Gordon DM. 2013. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep 5:58-65. http://dx.doi.org/10.1111/1758-2229.12019.
13. Johnson JR, Johnston B, Kuskowski MA, Sokurenko EV, Tchesnokova V. 2015. Intensity and mechanisms of fluoroquinolone resistance within the H30 and H30Rx subclones of Escherichia coli sequence type 131 compared with other fluoroquinolone-resistant E. coli. Antimicrob Agents Chemother 59:4471-4480. http://dx.doi.org/10.1128/AAC.00673-15.
14. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002-2004. Antimicrob Agents Chemother 53:2733-2739. http://dx.doi.org/10.1128/AAC.00297-09.
15. Clermont O, Christenson JK, Daubie AS, Gordon DM, Denamur E. 2014. Development of an allele-specific PCR for Escherichia coli B2 subtyping, a rapid and easy to perform substitute of multilocus sequence typing. J Microbiol Methods 101:24-27. http://dx.doi.org/10.1016/j.mimet.2014.03.008.
16. Matsumura Y, Yamamoto M, Nagao M, Hotta G, Matsushima A, Ito Y, Takakura S, Ichiyama S, Kyoto-Shiga Clinical Microbiology Study Group. 2012. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-beta-lactamase-producing Escherichia coli in Japan. J Antimicrob Chemother 67:2612-2620. http://dx.doi.org/10.1093/jac/dks278.
17. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
18. Sahm DF, Thornsberry C, Mayfield DC, Jones ME, Karlowsky JA. 2001. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 45:1402-1406. http://dx.doi.org/10.1128/AAC.45.5.1402-1406.2001.
19. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, Barrett TJ. 2006. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 3:59-67. http://dx.doi.org/10.1089/fpd.2006.3.59.
20. Johnson JR, Nicolas-Chanoine MH, DebRoy C, Castanheira M, Robicsek A, Hansen G, Weissman S, Urban C, Platell J, Trott D, Zhanel G, Clabots C, Johnston BD, Kuskowski MA, MASTER Investigators. 2012. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis 18:598-607. http://dx.doi.org/10.3201/eid1804.111627.
21. Sneath PHA, Sokal RR. 1973. Numerical taxonomy: the principles and practice of numerical classification, vol 2. W. H. Freeman & Co., San Francisco, CA.
22. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. 2001. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 345:1007-1013. http://dx.doi.org/10.1056/NEJMoa011265.
23. Riley LW. 2014. Pandemic lineages of extraintestinal pathogenic Escherichia coli. Clin Microbiol Infect 20:380-390. http://dx.doi.org/10.1111/1469-0691.12646.
24. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States (2007). Clin Infect Dis 51:286-294. http://dx.doi.org/10.1086/653932.
25. Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E. 2012. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun 80:1554-1562. http://dx.doi.org/10.1128/IAI.06388-11.
26. Peirano G, van der Bij AK, Freeman JL, Poirel L, Nordmann P, Costello M, Tchesnokova VL, Pitout JD. 2014. Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum beta-lactamases: global distribution of the H30-Rx sublineage. Antimicrob Agents Chemother 58:3762-3767. http://dx.doi.org/10.1128/AAC.02428-14.
27. Nowrouzian FL, Adlerberth I, Wold AE. 2006. Enhanced persistence in the colonic microbiota of Escherichia coli strains belonging to phylogenetic group B2: role of virulence factors and adherence to colonic cells. Microbes Infect 8:834-840. http://dx.doi.org/10.1016/j.micinf.2005.10.011.
28. Vimont S, Boyd A, Bleibtreu A, Bens M, Goujon JM, Garry L, Clermont O, Denamur E, Arlet G, Vandewalle A. 2012. The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS One 7:e46547. http://dx.doi.org/10.1371/journal.pone.0046547.
29. Boetius Hertz F, Lobner-Olesen A, Frimodt-Moller N. 2014. Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model. Antimicrob Agents Chemother 58:6139-6144. http://dx.doi.org/10.1128/AAC.03021-14.
30. Lau SH, Reddy S, Cheesbrough J, Bolton FJ, Willshaw G, Cheasty T, Fox AJ, Upton M. 2008. Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J Clin Microbiol 46:1076-1080. http://dx.doi.org/10.1128/JCM.02065-07.
31. Abraham SJD, Wong HS, ohnson, JR,Mark A Toleman MA, Wakeham DL, David M Gordon DM, Turnidge JD, Mollinger JL, Gibson JS, Trott DJ. 2015. First detection of extended-spectrum cephalosporin- and fluoroquinolone-resistant Escherichia coli in Australian food-producing animals. J Glob Antimicrob Resist 3:273-277. http://dx.doi.org/10.1016/j.jgar.2015.08.002.
32. Ewers CBA, Stamm I, Grobbel M, Kopp PA, Guerra B, Stubbe M, Doi Y, Zong Z, Kola A, Schaufler K, Semmler T, Fruth A, Wieler LH, Guenther S. 2014. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence? J Antimicrob Chemother 69:1224-1230. http://dx.doi.org/10.1093/jac/dkt516.